{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:51:10Z","timestamp":1787028670696,"version":"build-2736575974"},"reference-count":45,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2019,5,9]],"date-time":"2019-05-09T00:00:00Z","timestamp":1557360000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background: New biomarkers are urgently needed to facilitate diagnosis in Interstitial Lung Diseases (ILD), thus reducing the need for invasive procedures, and to enable tailoring and monitoring of medical treatment. Methods: In this study we investigated if patients with idiopathic pulmonary fibrosis (IPF; n = 21), non-IPF ILDs (n = 57) and other lung diseases (chronic obstructive pulmonary disease (COPD) n = 24, lung cancer (LC) n = 16) as well as healthy subjects (n = 20) show relevant differences in exhaled NO (FeNO; Niox MINO), or in eicosanoid (PGE2, 8-isoprostane; enzyme-linked immunosorbent assay (ELISA)) levels as measured in exhaled breath condensates (EBC) and bronchoalveolar lavage fluids (BALF). Results: There was no significant difference in FeNO values between IPF, non-IPF ILDs and healthy subjects, although some individual patients showed highly elevated FeNO. On the basis of the FeNO signal, it was neither possible to differentiate between the kind of disease nor to detect exacerbations. In addition, there was no correlation between FeNO values and lung function. The investigation of the eicosanoids in EBCs was challenging (PGE2) or unreliable (8-isoprostane), but worked out well in BALF. A significant increase of free 8-isoprostane was observed in BALF, but not in EBCs, of patients with IPF, hypersensitivity pneumonitis (HP) and sarcoidosis, possibly indicating severity of oxidative stress. Conclusions: FeNO-measurements are not of diagnostic benefit in different ILDs including IPF. The same holds true for PGE2 and 8-isoprostane in EBC by ELISA.<\/jats:p>","DOI":"10.3390\/jcm8050643","type":"journal-article","created":{"date-parts":[[2019,5,13]],"date-time":"2019-05-13T03:57:07Z","timestamp":1557719827000},"page":"643","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Exhalative Breath Markers Do Not Offer for Diagnosis of Interstitial Lung Diseases: Data from the European IPF Registry (eurIPFreg) and Biobank"],"prefix":"10.3390","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8682-4294","authenticated-orcid":false,"given":"Ekaterina","family":"Krauss","sequence":"first","affiliation":[{"name":"European IPF Registry &amp; Biobank (eurIPFreg\/bank), 35394 Giessen, Germany"},{"name":"Universities of Giessen and Marburg Lung Center (UGMLC), Member of the German Center for Lung Research (DZL), 35394 Giessen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maike","family":"Froehler","sequence":"additional","affiliation":[{"name":"European IPF Registry &amp; Biobank (eurIPFreg\/bank), 35394 Giessen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Degen","sequence":"additional","affiliation":[{"name":"Agaplesion Lung Clinic, 35753 Greifenstein, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7580-4738","authenticated-orcid":false,"given":"Poornima","family":"Mahavadi","sequence":"additional","affiliation":[{"name":"European IPF Registry &amp; Biobank (eurIPFreg\/bank), 35394 Giessen, Germany"},{"name":"Universities of Giessen and Marburg Lung Center (UGMLC), Member of the German Center for Lung Research (DZL), 35394 Giessen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth C.","family":"Dartsch","sequence":"additional","affiliation":[{"name":"Universities of Giessen and Marburg Lung Center (UGMLC), Member of the German Center for Lung Research (DZL), 35394 Giessen, Germany"},{"name":"Agaplesion Lung Clinic, 35753 Greifenstein, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Korfei","sequence":"additional","affiliation":[{"name":"European IPF Registry &amp; Biobank (eurIPFreg\/bank), 35394 Giessen, Germany"},{"name":"Universities of Giessen and Marburg Lung Center (UGMLC), Member of the German Center for Lung Research (DZL), 35394 Giessen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clemens","family":"Ruppert","sequence":"additional","affiliation":[{"name":"European IPF Registry &amp; Biobank (eurIPFreg\/bank), 35394 Giessen, Germany"},{"name":"Universities of Giessen and Marburg Lung Center (UGMLC), Member of the German Center for Lung Research (DZL), 35394 Giessen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1946-0894","authenticated-orcid":false,"given":"Werner","family":"Seeger","sequence":"additional","affiliation":[{"name":"European IPF Registry &amp; Biobank (eurIPFreg\/bank), 35394 Giessen, Germany"},{"name":"Universities of Giessen and Marburg Lung Center (UGMLC), Member of the German Center for Lung Research (DZL), 35394 Giessen, Germany"},{"name":"Cardio-Pulmonary Institute (CPI), EXC 2026, Project ID: 390649896, Justus-Liebig University Giessen, 35394 Giessen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Guenther","sequence":"additional","affiliation":[{"name":"European IPF Registry &amp; Biobank (eurIPFreg\/bank), 35394 Giessen, Germany"},{"name":"Universities of Giessen and Marburg Lung Center (UGMLC), Member of the German Center for Lung Research (DZL), 35394 Giessen, Germany"},{"name":"Agaplesion Lung Clinic, 35753 Greifenstein, Germany"},{"name":"Cardio-Pulmonary Institute (CPI), EXC 2026, Project ID: 390649896, Justus-Liebig University Giessen, 35394 Giessen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2019,5,9]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Mathai, S.K., and Schwartz, D.A. (2019). Translational research in pulmonary fibrosis. Transl. Res. J. Lab. Clin. Med., in press.","DOI":"10.1016\/j.trsl.2019.02.001"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/s12931-018-0845-5","article-title":"The European IPF registry (eurIPFreg): Baseline characteristics and survival of patients with idiopathic pulmonary fibrosis","volume":"19","author":"Guenther","year":"2018","journal-title":"Respir. Res."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12931-019-1010-5","article-title":"Psychometric properties and minimal important differences of SF-36 in Idiopathic Pulmonary Fibrosis","volume":"20","author":"Witt","year":"2019","journal-title":"Respir. Res."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1093\/toxsci\/kfu177","article-title":"Altered surfactant homeostasis and alveolar epithelial cell stress in amiodarone\u2013induced lung fibrosis","volume":"142","author":"Mahavadi","year":"2014","journal-title":"Toxicol. Sci."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1164\/rccm.200802-313OC","article-title":"Epithelial endoplasmic reticulum stress and apoptosis in sporadic idiopathic pulmonary fibrosis","volume":"178","author":"Korfei","year":"2008","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/S2213-2600(17)30433-2","article-title":"Diagnostic criteria for idiopathic pulmonary fibrosis: A Fleischner Society White Paper","volume":"6","author":"Lynch","year":"2018","journal-title":"Lancet Respir. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/j.chest.2019.01.019","article-title":"Lung CT densitometry in idiopathic pulmonary fibrosis (IPF) for the prediction of natural course, severity and mortality","volume":"155","author":"Loeh","year":"2019","journal-title":"Chest"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Ravaglia, C., Wells, A.U., Tomassetti, S., Gurioli, C., Gurioli, C., Dubini, A., Cavazza, A., Colby, T.V., Piciucchi, S., and Puglisi, S. (2019). Diagnostic yield and risk\/benefit analysis of trans\u2013bronchial lung cryobiopsy in diffuse parenchymal lung diseases: A large cohort of 699 patients. BMC Pulm. Med., 19.","DOI":"10.1186\/s12890-019-0780-3"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1164\/rccm.201807-1255ST","article-title":"Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS\/ERS\/JRS\/ALAT Clinical Practice Guideline","volume":"198","author":"Raghu","year":"2018","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.matbio.2018.01.023","article-title":"Biomarkers in idiopathic pulmonary fibrosis","volume":"68\u201369","author":"Drakopanagiotakis","year":"2018","journal-title":"Matrix Biol. J. Int. Soc. Matrix Biol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12931-019-0971-8","article-title":"Breath biomarkers in idiopathic pulmonary fibrosis: A systematic review","volume":"20","author":"Hayton","year":"2019","journal-title":"Respir. Res."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s12931-018-0754-7","article-title":"Evaluation of oxidative stress biomarkers in idiopathic pulmonary fibrosis and therapeutic applications: A systematic review","volume":"19","author":"Fois","year":"2018","journal-title":"Respir. Res."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S2213-2600(18)30185-1","article-title":"Prognostic and predictive biomarkers for patients with idiopathic pulmonary fibrosis treated with pirfenidone: Post-hoc assessment of the CAPACITY and ASCEND trials","volume":"6","author":"Neighbors","year":"2018","journal-title":"Lancet Respir. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s12931-018-0730-2","article-title":"Idiopathic pulmonary fibrosis: Pathogenesis and management","volume":"19","author":"Sgalla","year":"2018","journal-title":"Respir. Res."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.resinv.2018.06.001","article-title":"Significance of molecular biomarkers in idiopathic pulmonary fibrosis: A mini review","volume":"56","author":"Chiba","year":"2018","journal-title":"Respir. Investig."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s00408-018-0140-8","article-title":"Tissue and Bronchoalveolar Lavage Biomarkers in Idiopathic Pulmonary Fibrosis Patients on Pirfenidone","volume":"196","author":"Ronan","year":"2018","journal-title":"Lung"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1164\/rccm.201512-2316PP","article-title":"Idiopathic Pulmonary Fibrosis: Novel Concepts of Proton Pump Inhibitors as Antifibrotic Drugs","volume":"193","author":"Ghebre","year":"2016","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/path.4127","article-title":"The role of dimethylarginine dimethylaminohydrolase (DDAH) in pulmonary fibrosis","volume":"229","author":"Janssen","year":"2013","journal-title":"J. Pathol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1016\/j.rmed.2013.07.007","article-title":"Can exhaled nitric oxide differentiate causes of pulmonary fibrosis?","volume":"107","author":"Guilleminault","year":"2013","journal-title":"Respir. Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/cea.13251","article-title":"NOx in exhaled breath condensate is related to allergic sensitization in young and middle-aged adults","volume":"49","author":"Aldakheel","year":"2018","journal-title":"Clin. Exp. Allergy J. Br. Soc. Allergy Clin. Immunol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1089\/ped.2018.0886","article-title":"Asthma Endotyping and Biomarkers in Childhood Asthma","volume":"31","author":"Licari","year":"2018","journal-title":"Pediatr. Allergy Immunol. Pulmonol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1378\/chest.09-2090","article-title":"Exhaled nitric oxide in pulmonary diseases: A comprehensive review","volume":"138","author":"Barnes","year":"2010","journal-title":"Chest"},{"key":"ref_23","first-page":"39","article-title":"Exhaled nitric oxide is not increased in pulmonary sarcoidosis","volume":"33","author":"Cameli","year":"2016","journal-title":"Sarcoidosis Vasc. Diffuse Lung Dis."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"5112","DOI":"10.4049\/jimmunol.1502153","article-title":"Alveolar epithelial cell\u2013derived prostaglandin E2 serves as a request signal for macrophage secretion of suppressor of cytokine signaling 3 during innate inflammation","volume":"196","author":"Speth","year":"2016","journal-title":"J. Immunol. (Baltimore Md. 1950)"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1165\/rcmb.2014-0468OC","article-title":"Reversal of the Transcriptome by Prostaglandin E2 during Myofibroblast Dedifferentiation","volume":"54","author":"Wettlaufer","year":"2016","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1161\/01.ATV.17.11.2309","article-title":"Isoprostanes: Potential markers of oxidant stress in atherothrombotic disease","volume":"17","author":"Patrono","year":"1997","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1164\/ajrccm.153.2.8564103","article-title":"8-Epi-PGF2 alpha, a novel noncyclooxygenase-derived prostaglandin, constricts airways in vitro","volume":"153","author":"Kawikova","year":"1996","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.fct.2013.05.016","article-title":"8\u2013isoprostane levels in serum and bronchoalveolar lavage in idiopathic pulmonary fibrosis and sarcoidosis","volume":"61","author":"Malli","year":"2013","journal-title":"Food Chem. Toxicol. Int. J. Publ. Br. Ind. Biol. Res. Assoc."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1600965","DOI":"10.1183\/13993003.00965-2016","article-title":"A European Respiratory Society technical standard: Exhaled biomarkers in lung disease","volume":"49","author":"Barnes","year":"2017","journal-title":"Eur. Respir. J."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s40733-018-0045-6","article-title":"Exhaled biomarkers in childhood asthma: Old and new approaches","volume":"4","author":"Ferraro","year":"2018","journal-title":"Asthma Res. Pract."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1164\/rccm.9120-11ST","article-title":"An official ATS clinical practice guideline: Interpretation of exhaled nitric oxide levels (FENO) for clinical applications","volume":"184","author":"Dweik","year":"2011","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1378\/chest.13-0843","article-title":"A novel approach to partition central and peripheral airway nitric oxide","volume":"145","author":"Paredi","year":"2014","journal-title":"Chest"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1183\/09031936.00112306","article-title":"Bronchoalveolar lavage, sputum and exhaled clinically relevant inflammatory markers: Values in healthy adults","volume":"30","author":"Balbi","year":"2007","journal-title":"Eur. Respir. J."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1378\/chest.10-1157","article-title":"Increased nitric oxide concentrations in the small airway of older normal subjects","volume":"139","author":"Gelb","year":"2011","journal-title":"Chest"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.2147\/COPD.S165780","article-title":"Exhaled nitric oxide in patients with chronic obstructive pulmonary disease: A systematic review and meta-analysis","volume":"13","author":"Lu","year":"2018","journal-title":"Int. J. Chronic Obstr. Pulm. Dis."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1164\/ajrccm.163.7.2010171","article-title":"Extended exhaled NO measurement differentiates between alveolar and bronchial inflammation","volume":"163","author":"Kankaanranta","year":"2001","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1164\/ajrccm.155.5.9154889","article-title":"Increased production of the potent oxidant peroxynitrite in the lungs of patients with idiopathic pulmonary fibrosis","volume":"155","author":"Saleh","year":"1997","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1378\/chest.115.5.1352","article-title":"Exhaled nitric oxide is increased in active fibrosing alveolitis","volume":"115","author":"Paredi","year":"1999","journal-title":"Chest"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Cameli, P., Bargagli, E., Bergantini, L., Refini, R.M., Pieroni, M., Sestini, P., and Rottoli, P. (2019). Evaluation of multiple-flows exhaled nitric oxide in idiopathic and non-idiopathic interstitial lung disease. J. Breath Res.","DOI":"10.1088\/1752-7163\/ab0233"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1055\/s-0030-1255958","article-title":"Stickstoffmonoxyd in der Atemluft von Patienten mit interstitiellen Lungenkrankheiten","volume":"65","author":"Schildge","year":"2011","journal-title":"Pneumologie (Stuttg. Ger.)"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1172\/JCI117866","article-title":"Cultured lung fibroblasts isolated from patients with idiopathic pulmonary fibrosis have a diminished capacity to synthesize prostaglandin E2 and to express cyclooxygenase-2","volume":"95","author":"Wilborn","year":"1995","journal-title":"J. Clin. Investig."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"32231","DOI":"10.1074\/jbc.M111.235606","article-title":"Plasmin overcomes resistance to prostaglandin E2 in fibrotic lung fibroblasts by reorganizing protein kinase A signaling","volume":"286","author":"Okunishi","year":"2011","journal-title":"J. Biol. Chem."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1164\/rccm.200905-0674OC","article-title":"Diminished prostaglandin E2 contributes to the apoptosis paradox in idiopathic pulmonary fibrosis","volume":"182","author":"Maher","year":"2010","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1111\/j.1365-2362.2006.01636.x","article-title":"Exhaled markers of oxidative stress in idiopathic pulmonary fibrosis","volume":"36","author":"Psathakis","year":"2006","journal-title":"Eur. J. Clin. Investig."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1164\/ajrccm.158.5.9803102","article-title":"8-Isoprostane as a biomarker of oxidative stress in interstitial lung diseases","volume":"158","author":"Montuschi","year":"1998","journal-title":"Am. J. Respir. Crit. Care Med."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/8\/5\/643\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T12:50:34Z","timestamp":1760187034000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/8\/5\/643"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,9]]},"references-count":45,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2019,5]]}},"alternative-id":["jcm8050643"],"URL":"https:\/\/doi.org\/10.3390\/jcm8050643","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,9]]}}}